Professional Practice Standards v4 2010 · PDF file4 Professional Practice Standards ... As...

download Professional Practice Standards v4 2010 · PDF file4 Professional Practice Standards ... As health professionals with a wide-ranging body of knowledge and skills with regard to medicines

If you can't read please download the document

Transcript of Professional Practice Standards v4 2010 · PDF file4 Professional Practice Standards ... As...

  • Professional Practice Standards

    VERSION 4 2010

    Professio

    nal Practice S

    tandard

    s | VE

    RS

    ION

    4 | 2010

    PS

    A2524

  • The Professional Practice Standards version 4 has been endorsed by the following organisations at the time of publication.

    A A C PAUSTRALIAN ASSOCIATION

    OF CONSULTANT PHARMACY

    Pharmaceutical Society of Australia 2010

    The material in this publication has been provided by the Pharmaceutical Society of Australia (PSA). The PSA retains copyright in the publication as a whole and in all material in the publication that is authored by or on behalf of the PSA.

    Apart from any use permitted under the Copyright Act 1968, you must not make any other use of this material unless you have written permission to do so. Requests and enquiries regarding permission to use PSA material should be addressed to:

    Publications Manager Pharmaceutical Society of Australia PO Box 42 Deakin West ACT 2600

    The review of the Professional Practice Standards is funded by the Australian Government Department of Health and Ageing and developed by the PSA with support from the Pharmacy Guild of Australia as part of the Fourth Community Pharmacy Agreement.

    Disclaimer

    These standards have been designed for use by individual pharmacists to assess their own professional practice. They are intended to serve as guidance for desired standards of practice. However, it is the sole responsibility of the individual pharmacist to determine, in all circumstances, whether a higher standard is required. It is equally their responsibility to meet that standard.

    The PSA has made every effort to ensure that, at the date of publication, the document is free from errors and that the advice and information drawn upon have been provided in good faith. However, the information contained in this publication is dynamic in nature due to ongoing research and change in government regulation and pharmacy practice. Neither the PSA nor any other person associated with the preparation of this document accepts liability for any loss that a user of this document may suffer as a result of reliance on the document and, in particular, for:

    use of the document for a purpose for which it was not intended any errors or omissions in the document any inaccuracy in the information or data on which the document

    is based or which are contained in the document OR any interpretations or opinions stated in, or which may be inferred

    from, the document.

    Notification of any inaccuracy or ambiguity found in this document should be made without delay in order that the issue may be investigated and appropriate action taken. Please forward your notification to:

    Policy and Practice Group Pharmaceutical Society of Australia PO Box 42 Deakin West ACT 2600

    ISBN: 978-0-646-53402-2 Title: Professional Practice Standards Version 4 June 2010 Edition: 4th Date of Publication: June 2010 Publisher: Pharmaceutical Society of Australia

  • 3Professional Practice Standards | Version 4 | 2010 | Pharmaceutical Society of Australia

    Fo

    rew

    ord

    Contents

    Foreword .......................................................................................................................................................................................................................... 4

    Introduction

    The Professional Practice Standards and the practice of pharmacy ............................................................................................ 5Background to the Professional Practice Standards ......................................................................................................................... 5The broader context of guidance supporting pharmacy practice .................................................................................................. 5General resources for pharmacists ........................................................................................................................................................... 6How to use the Professional Practice Standards ................................................................................................................................ 6Significant updates in the Professional Practice Standards, version 4 ........................................................................................ 6A guide to reading the standards .............................................................................................................................................................. 9

    Professional Practice Standards

    Standard 1: Fundamental Pharmacy Practice................................................................................................................................11Standard 2: Managing Pharmacy Practice ......................................................................................................................................15Standard 3: Counselling .........................................................................................................................................................................20Standard 4: Medication Review ..........................................................................................................................................................24Standard 5: Dispensing ..........................................................................................................................................................................28Standard 6: Indirect Pharmacy Services ..........................................................................................................................................33Standard 7: Dose Administration Aids Service ..............................................................................................................................36Standard 8: Services to Residential Care Facilities ......................................................................................................................40Standard 9: Continuity of Care through Medication Liaison Services ....................................................................................44Standard 10: Compounding (also known as Extemporaneous Dispensing) ..........................................................................47Standard 11: Compounding Sterile Preparations ............................................................................................................................53Standard 12: Provision of Non-prescription Medicines and Therapeutic Devices ...............................................................57Standard 13: Health Promotion .............................................................................................................................................................60Standard 14: Medicines Information Centres ....................................................................................................................................62Standard 15: Pharmacy Services to Aboriginal and Torres Strait Islander Health Services ..............................................65Standard 16: Screening and Risk Assessment ................................................................................................................................68Standard 17: Disease State Management .........................................................................................................................................72Standard 18: Harm Minimisation ...........................................................................................................................................................76

    Appendices

    Appendix 1: The Medicines Management Pathway ......................................................................................................................81Appendix 2: Quality Use of Medicines and Practice Improvement ..........................................................................................84Appendix 3: The Health Promotion Planning Cycle ......................................................................................................................86Appendix 4: Adherence Assessment Tool ........................................................................................................................................87Appendix 5: Details of Local Health Care Providers .....................................................................................................................88 Appendix 6: Documenting Counselling Events and Interventions ............................................................................................89Appendix 7: Indirect Supply Services: New Consumer Details/Change of Consumer Details Form ...........................90Appendix 8: Medicines that may be Considered Unsuitable for Indirect Supply ................................................................91Appendix 9: Template Procedure for Consumer Admissions and Readmissions to Residential Care Facilities ........................................................................................................................................92Appendix 10: Screening Record and Referral Form ........................................................................................................................93Appendix 11: Template Consumer Care Plan ...................................................................................................................................95Appendix 12: The History of the Professional Practice Standards ............................................................................................97Appendix 13: Project Participants ..........................................................